Latest SRPT reports update at 2024-05-01: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Sarepta Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Sarepta Therapeutics logo
Sarepta Therapeutics SRPT
$ 129.86 4.35%
mail-toReport an Error

Sarepta Therapeutics EV/EBITDA Ratio 2011-2024 | SRPT

Annual EV/EBITDA Ratio Sarepta Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-14.9 -11.6 -16.3 -25.1 -26.1 -5.04 -2.07 -3.18 -6.64 -16.1 -2.27

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.07 -26.1 -11.8